Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 14
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Barcoding Alaska

    We want to DNA barcode plants of the Alaskan wild with the help of citizen scientists and local Brooklyn...

    Who's up there? Effects of land use on canopy plants in cloud forests and pastures of Monteverde, Costa Rica

    Epiphytes grow in the canopy of trees, deriving support from their hosts, but getting water and nutrients...

    Backer Badge Funded